Literature DB >> 11484071

Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes.

L T Dalgaard1, O Pedersen.   

Abstract

Uncoupling proteins are mitochondrial carrier proteins which are able to dissipate the proton gradient of the inner mitochondrial membrane. This uncoupling process reduces the amount of ATP generated through an oxidation of fuels. The hypothesis that uncoupling proteins (UCPs) are candidate genes for human obesity or Type II (non-insulin-dependent) diabetes mellitus is based on the finding that a chemical uncoupling of the mitochondrial membrane reduces body adiposity, and that lower metabolic rates predict weight gain. It is straightforward to hypothesize that common polymorphisms of UCP1, UCP2 and UCP3 genes lower metabolic rate by a more efficient energy coupling in the mitochondria. Furthermore, genetically engineered mice over expressing different UCP homologues are lean and resistant to diet-induced obesity. The three uncoupling protein homologue genes UCP1, UCP2, and UCP3 have been investigated for polymorphisms and mutations and their impact on Type II diabetes mellitus, obesity, and body weight gain or BMI. The main conclusion is that variation in the UCP1, UCP2 or UCP3 genes is not associated with major alterations of body weight gain. The contribution of UCP genes towards polygenic obesity and Type II diabetes is evaluated and discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11484071     DOI: 10.1007/s001250100596

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  60 in total

Review 1.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

Authors:  J S Armstrong
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

3.  Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota.

Authors:  Jianjun Zhang; Ishwori B Dhakal; Xuemei Zhang; Anna E Prizment; Kristin E Anderson
Journal:  Pancreas       Date:  2014-03       Impact factor: 3.327

4.  Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population.

Authors:  Tun-Jen Hsiao; Lawrence Shih-Hsin Wu; Yuchi Hwang; Shih-Yi Huang; Eugene Lin
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

5.  UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study.

Authors:  K Xu; M Zhang; D Cui; Y Fu; L Qian; R Gu; M Wang; C Shen; R Yu; T Yang
Journal:  Diabetologia       Date:  2011-07-13       Impact factor: 10.122

6.  Human uncoupling protein 2 and 3 genes are associated with obesity in Japanese.

Authors:  Kotoko Kosuge; Masayoshi Soma; Tomohiro Nakayama; Noriko Aoi; Mikano Sato; Akira Haketa; Jiro Uwabo; Yoichi Izumi; Koichi Matsumoto
Journal:  Endocrine       Date:  2008-10-28       Impact factor: 3.633

7.  A common polymorphism in the promoter of UCP2 is associated with obesity and hyperinsulenemia in northern Indians.

Authors:  Neena Srivastava; Jai Prakash; Ram Lakhan; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2009-11-12       Impact factor: 3.396

Review 8.  The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes.

Authors:  Jun-jing Jia; Yun-bo Tian; Zhen-hui Cao; Lin-li Tao; Xi Zhang; Si-zhen Gao; Chang-rong Ge; Qiu-Ye Lin; M Jois
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

Review 9.  Nuclear transcription factors in mammalian mitochondria.

Authors:  Sarah Leigh-Brown; José Antonio Enriquez; Duncan T Odom
Journal:  Genome Biol       Date:  2010-07-29       Impact factor: 13.583

10.  Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: the Finnish Diabetes Prevention Study.

Authors:  Titta Salopuro; Leena Pulkkinen; Jaana Lindström; Marjukka Kolehmainen; Anna-Maija Tolppanen; Johan G Eriksson; Timo T Valle; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Markku Laakso; Matti Uusitupa
Journal:  BMC Med Genet       Date:  2009-09-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.